CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness.
Saved in:
| Title: | CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness. |
|---|---|
| Authors: | Castellanos MM; Drug Product Development, Vaccines Technical R&D, GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA., Gressard H; Project & Digital Sciences, Vaccines Technical R&D, GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium., Li X; Drug Substance Development, Vaccines Technical R&D, GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA., Magagnoli C; Analytical Research & Development, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy., Moriconi A; Drug Product Development, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy., Stranges D; Drug Product Development, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy., Strodiot L; Drug Product Development, Vaccines Technical R&D, GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium., Tello Soto M; Drug Substance Development, Vaccines Technical R&D, GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium., Zwierzyna M; Project & Digital Sciences, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy., Campa C; Vaccines Global Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy. |
| Source: | Vaccines [Vaccines (Basel)] 2023 Jun 26; Vol. 11 (7). Date of Electronic Publication: 2023 Jun 26. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37514969 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Castellanos+MM%22">Castellanos MM</searchLink>; Drug Product Development, Vaccines Technical R&D, GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA.<br /><searchLink fieldCode="AU" term="%22Gressard+H%22">Gressard H</searchLink>; Project & Digital Sciences, Vaccines Technical R&D, GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Drug Substance Development, Vaccines Technical R&D, GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA.<br /><searchLink fieldCode="AU" term="%22Magagnoli+C%22">Magagnoli C</searchLink>; Analytical Research & Development, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Moriconi+A%22">Moriconi A</searchLink>; Drug Product Development, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Stranges+D%22">Stranges D</searchLink>; Drug Product Development, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Strodiot+L%22">Strodiot L</searchLink>; Drug Product Development, Vaccines Technical R&D, GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Tello+Soto+M%22">Tello Soto M</searchLink>; Drug Substance Development, Vaccines Technical R&D, GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Zwierzyna+M%22">Zwierzyna M</searchLink>; Project & Digital Sciences, Vaccines Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Campa+C%22">Campa C</searchLink>; Vaccines Global Technical R&D, GSK, Via Fiorentina 1, 53100 Siena, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2023 Jun 26; Vol. 11 (7). <i>Date of Electronic Publication: </i>2023 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37514969 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/vaccines11071153 Languages: – Code: eng Text: English Titles: – TitleFull: CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Castellanos MM – PersonEntity: Name: NameFull: Gressard H – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Magagnoli C – PersonEntity: Name: NameFull: Moriconi A – PersonEntity: Name: NameFull: Stranges D – PersonEntity: Name: NameFull: Strodiot L – PersonEntity: Name: NameFull: Tello Soto M – PersonEntity: Name: NameFull: Zwierzyna M – PersonEntity: Name: NameFull: Campa C IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 06 Text: 2023 Jun 26 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2076-393X Numbering: – Type: volume Value: 11 – Type: issue Value: 7 Titles: – TitleFull: Vaccines Type: main |
| ResultId | 1 |
